Novavax Q2 2024: Sanofi Deal Boosts Revenue
Novavax reports $415M in Q2 revenue with Sanofi's help, eyeing new vaccine launches and cost reductions.
- Latest
- Trending
Novavax reports $415M in Q2 revenue with Sanofi's help, eyeing new vaccine launches and cost reductions.
Tether aims to double its workforce by mid-2025 to enhance compliance and finance operations amid growing regulatory scrutiny.
The University of Nebraska offers new courses in esports media and AI, preparing students for emerging tech careers.
Maximus reports 10.6% revenue growth, raises FY2024 guidance, focusing on technology and customer service investments.
Himax Technologies Q2 revenue up by 15.5%, focusing on long-term growth despite projected Q3 revenue decline.
Top altcoins may rise based on key metrics. Analyst Jamie Coutts explains the trends.
Dogecoin and Cardano rebound amid FED rate cut talks with Rollblock hitting new highs. Explore potential growth in crypto assets.
Recursion Pharmaceuticals acquires Exscientia to enhance AI drug discovery, potentially saving millions in drug development costs.
Moody's downgrades Intel's rating to BAA1, citing profitability concerns and changes outlook to negative.
Commerzbank maintains 2024 goals despite Q2 challenges, plans €1.6B capital return. Solid loan demand and strategic investments.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.